معرفی
Jonathan D. Mahnken is a Professor of Biostatistics & Data Science at the University of Kansas Medical Center. He serves as Director of the Data Management and Statistical Core for the University of Kansas Alzheimer’s Disease Research Center since 2011 and co-lead for the Research Methods Core for Frontiers, the Clinical and Translational Science Institute, since 2020. With over 100 publications, his work focuses on biostatistical methods applied to biomedical research, particularly in Alzheimer's disease and related conditions.
His educational background includes:
- PhD in Biometry from the University of Texas Health Science Center
- MS in Preventive Medicine from the University of Texas Medical Branch
- BA in Mathematics from Concordia University, Seward
Dr. Mahnken's research expertise centers on advanced statistical methods for biomedical data, including study design, analysis of categorical and censored data, and complex model parameterizations. He provides comprehensive guidance on data management, interpretation of results, and manuscript development. His work is instrumental in translating statistical insights into actionable biomedical knowledge, with a strong emphasis on collaborative research in aging and neurodegenerative diseases.
Analysis of his recent publications (2024-2025) reveals a strong focus on Alzheimer's disease research, particularly in nutrition, exercise, metabolic interventions, and social determinants of health. His work frequently involves interdisciplinary collaborations and utilizes innovative statistical approaches to address complex questions in clinical and translational science.
Dr. Mahnken actively mentors junior faculty both within and outside his department and has contributed as a co-investigator on multiple NIH-funded research programs since joining KUMC in 2004. His leadership in the Data Management and Statistical Core and the Research Methods Core underscores his commitment to advancing methodological rigor in clinical research.
He is integral to the University of Kansas Alzheimer’s Disease Research Center and Frontiers CTSI, where his teams provide critical statistical support for large-scale research initiatives aimed at understanding and combating Alzheimer's disease and improving clinical and translational research methodologies.
